Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Discovery on Cause of Rare Genetic Bone Disease Detailed in Science Translational Medicine Publication

09/02/15

Tarrytown, New York (September 2, 2015) - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Science Translational Medicine has published a paper describing the discovery and preclinical validation of a key biologic mechanism that driv...

Read more

Upcoming Events

Baird 2015 Healthcare Conference

09/09/15 at 12:50 PM ET

View Event

Morgan Stanley Global Healthcare Conference

09/16/15 at 12:30 PM ET

View Event




Close
Form content here please :)